Why CRISPR Therapeutics Stock Rocked the Market Last Month
The company had fallen out of investor favor; its recovery was impressive.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Auto & Transport Roundup: Market Talk
Find insight on Volkswagen, HD Korea Shipbuilding & Offshore Engineering, Mobico and more in the latest Market Talks covering Auto and Transport.
Shares of AVGB Now Oversold
In trading on Tuesday, shares of the Avantis Credit ETF (Symbol: AVGB) entered into oversold territory, changing hands as low as $50.36 per share.
Here's the One Storage Stock I'd Buy With $2,000
Nearly every drive the hard drive maker can build this year is already spoken for. Which storage stock does all that locked-in demand reward most?
UAE jumps to world No.2 crypto hub with perfect 10 for tax friendliness
UAE rises from fifth to second in Henley’s 2026 global crypto ranking, scoring 10/10 for tax friendliness as crypto wealth reaches $2.6tn
Peru’s monetary system would not work in Venezuela
As Venezuela's National Assembly debates how to kill the world's highest inflation rate, two economists argue that copying Peru would be a mistake.